Table 5 |
||||||
|
Haplotype specific odds ratios adjusted for age and association with tumor characteristics |
||||||
|
Haplotypea |
Positive nodes |
ER status |
PR status |
|||
|
|
||||||
|
OR (95% CI) |
P |
OR (95% CI) |
P |
OR (95% CI) |
P |
|
|
|
||||||
|
1 |
1.00 |
1.00 |
1.00 |
|||
|
2 |
1.14 (0.52–2.51) |
0.7410 |
0.93 (0.34–2.60) |
0.8961 |
0.99 (0.42–2.33) |
0.9828 |
|
3 |
2.20 (1.27–3.81) |
0.0051* |
0.62 (0.30–1.29) |
0.2005 |
1.50 (0.82–2.77) |
0.1915 |
|
4 |
1.00 (0.54–1.86) |
0.9940 |
2.85 (1.36–5.94) |
0.0053* |
2.16 (1.13–4.12 |
0.0199* |
|
|
||||||
|
aHaplotypes with an estimated frequency under 1% were pooled within the baseline for the purposes of analysis. *Statistically significant comparisons of haplotype frequencies. |
||||||
|
Crawford et al. Breast Cancer Research 2006 8:R16 doi:10.1186/bcr1389 |
||||||
